RE:Just too bad....One thing we know, fall (& into winter a bit) will bring clarity one way or another. Right now, it's all about SORT1+ for seeing the possibility of step function gains. NASH is a side project, fairly low expectations, and likely just part of the LSA playbook on education around pipeline. Don't expect much and be surprised if there is anything we don't already know.
Another reason it's all about SORT1+ is that the 4 investors that came in to lead the ONO are there mostly for cancer. They understand it, know what it can lead to, and are looking to make as much money as they can off their knowledge. They probably don't actually know a whole lot more than we do here. They are looking to also narrow down their list of possible outcomes from failure to success. If the data skews the confidence interval toward success or even just eliminates the negative tail portion heavily, they won't let the opportunity slide by to make even more money on it and will likely start buying with a view that up 15-20-30% is nothing if their models show there's a higher probability of it being worth 3-5x more. So don't worry about volumes or NASH, worry about getting positive data around SORT1+.
We will all break the Smile-O-Meter if so.
FredTheVoice wrote: Just too bad you are leaving LEE,
Just a normal and temporary thing whats going on,
Money is sleeping......
Tension is high without news on NASH and CANCER,
Do you remember the level of tension just before TROG approval here......hey....
Lets hope fall will bring clarity very soon,
GLTA
F.